Transcription Factor E2F-1 Is Upregulated in Response to DNA Damage in a Manner Analogous to That of p53

• Published in: Molecular and Cellular Biology Vol. 19; no. 5; pp. 3704 - 3713
• Main Authors: Blattner, Christine, Sparks, Alison, Lane, David
• Format: Journal Article
• Language: English
• Published: United States American Society for Microbiology 01.05.1999; Taylor & Francis
• Subjects: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - pharmacology; Antibodies - pharmacology; Carrier Proteins; Cell Cycle Proteins; Cell Growth and Development; Dactinomycin - pharmacology; Dichlororibofuranosylbenzimidazole - pharmacology; DNA Damage - genetics; DNA-Binding Proteins; E2F Transcription Factors; E2F1 Transcription Factor; Enzyme Inhibitors - pharmacology; Fluorescent Antibody Technique; Gene Expression Regulation - genetics; Humans; Mutation; Nuclear Proteins; Oligonucleotides, Antisense - genetics; Oligonucleotides, Antisense - pharmacology; Proto-Oncogene Proteins - genetics; Proto-Oncogene Proteins c-mdm2; Retinoblastoma-Binding Protein 1; RNA, Messenger - metabolism; Transcription Factor DP1; Transcription Factors - genetics; Transcription, Genetic - radiation effects; Tumor Cells, Cultured; Tumor Suppressor Protein p53 - genetics; Up-Regulation

Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue MCB About MCB Subscribers Authors Reviewers Advertisers Inquiries from...